Migraines and headaches are a global burden that needs greater recognition, international study finds

Migraines and headaches are a prevalent global issue that continues to impact a large portion of the world’s population. According to a recent study published in Cell Reports Medicine, modern lifestyles characterized by stress, sedentary behavior, caffeine consumption, alcohol intake, and poor-quality sleep are common triggers for these debilitating conditions. The research, led by neurology experts from La Trobe University and Western Health, highlights the need for greater recognition and support for the 2.8 billion individuals worldwide who suffer from migraines and headaches.

The COVID-19 pandemic has added further challenges to headache management, with reports of acute or chronic headaches emerging post-SARS-CoV-2 infection or vaccination. This has compounded the global burden of migraine-related issues, emphasizing the importance of increased healthcare funding and awareness for these conditions.

The study, which analyzed data from the Global Burden of Diseases study across 204 countries and territories, revealed that women aged 30-44 and individuals from higher-income countries with better healthcare quality are disproportionately affected by headache disorders. While migraines are less common, they are significantly more disabling than other types of headaches.

Individuals co-infected with migraines and SARS-CoV-2 have reported experiencing more severe pain that is often less responsive to standard pain medications. The study also noted that factors such as increased psychological stress, disrupted healthcare access, and social challenges have further complicated the management of migraine and headache disorders.

Lead researcher, Professor Tissa Wijeratne, emphasized the need for tailored interventions and resources to address the burden of these conditions in the coming years. Despite advancements in diagnostic tools and treatment options, the enduring influence of modern risk factors is expected to maintain prevalence rates unless significant changes are made.

The study underscores the urgent need to prioritize migraine and headache disorders on a global health agenda. By recognizing the impact of these conditions and implementing targeted interventions, the burden of migraines and headaches can be reduced in the future.

For more information, the full study titled “Global, regional, and national burden of headache disorders, 1990–2021, with forecasts to 2050: A Global Burden of Disease study 2021” can be accessed in Cell Reports Medicine (2025) with DOI: 10.1016/j.xcrm.2025.102348. This research was conducted by La Trobe University and serves as a crucial step towards addressing the global burden of migraines and headaches.